M.A. Lijkwan
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Surgery 8
- Transplantation: Methods and Outcomes 5
- Peripheral Artery Disease Management 2
-
- Angiogenesis and VEGF in Cancer 2
- Pluripotent Stem Cells Research 1
- Co-authors
- Robert C. Robbins (13 shared papers)Joseph C. Wu (5 shared papers)Ning Sun (1 shared paper)Shijun Hu (1 shared paper)Zongjin Li (1 shared paper)Zhumur Ghosh (1 shared paper)Xi Wang (1 shared paper)Mei Huang (1 shared paper)
- Journals
- The Journal of Heart and Lung Transplantation (7 papers)Transplantation (3 papers)Circulation (1 paper)Human Gene Therapy (1 paper)Trends in Cardiovascular Medicine (1 paper)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
M.A. Lijkwan
21 papers receiving 748 citations
M.A. Lijkwan's Hit Papers
Peers
Comparison fields: 5 of 75
- Cancer Research 273
- Transplantation 15
- Molecular Biology 395
- Genetics 50
- Biomaterials 59
Countries citing papers authored by M.A. Lijkwan
This map shows the geographic impact of M.A. Lijkwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Lijkwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Lijkwan more than expected).
Fields of papers citing papers by M.A. Lijkwan
This network shows the impact of papers produced by M.A. Lijkwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Lijkwan. The network helps show where M.A. Lijkwan may publish in the future.
Co-authors
The 25 scholars most cited alongside M.A. Lijkwan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease Hit paper breakdown → | 2010 | 404 |
| 2 | 2010 | 82 | |
| 3 | 2018 | 82 | |
| 4 | 2012 | 39 | |
| 5 | 2013 | 28 | |
| 6 | 2004 | 23 | |
| 7 | 2011 | 19 | |
| 8 | 2002 | 18 | |
| 9 | 2003 | 10 | |
| 10 | 2003 | 8 | |
| 11 | 2005 | 7 | |
| 12 | 2003 | 6 | |
| 13 | 2004 | 6 | |
| 14 | 2002 | 5 | |
| 15 | 2002 | 5 | |
| 16 | 2019 | 3 | |
| 17 | 2010 | 3 | |
| 18 | 2003 | 3 | |
| 19 | 2002 | 2 | |
| 20 | 2025 | 1 |
About M.A. Lijkwan
M.A. Lijkwan is a scholar working on Surgery, Molecular Biology, Cardiology and Cardiovascular Medicine, Genetics and General Health Professions, having authored 21 papers that have together received 755 indexed citations. Recurring topics across this work include Transplantation: Methods and Outcomes (5 papers), Angiogenesis and VEGF in Cancer (2 papers), Viral Infections and Immunology Research (2 papers), Peripheral Artery Disease Management (2 papers), Electrospun Nanofibers in Biomedical Applications (1 paper), Marine Biology and Environmental Chemistry (1 paper), Aortic aneurysm repair treatments (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Cancer Research (273 citations), Transplantation (15 citations), Molecular Biology (395 citations), Genetics (50 citations) and Biomaterials (59 citations). M.A. Lijkwan has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Robert C. Robbins, Joseph C. Wu, Ning Sun, Shijun Hu, Zongjin Li, Zhumur Ghosh, Xi Wang, Mei Huang, Fangjun Jia and Fabio Martelli. Their work appears in journals such as The Journal of Heart and Lung Transplantation, Transplantation, Circulation, Human Gene Therapy and Trends in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.